Adherence to cardiovascular disease risk factor medications among patients with cancer: a systematic review

ConclusionsCVD risk factor-related medication adherence is low among cancer survivors and declines over time. Given the risk for CVD-mortality among cancer survivors, testing of interventions aimed at improving adherence to non-cancer medications is critically needed.Implications for Cancer SurvivorsFor many cancer survivors, regularly taking medications to manage CVD risk is important for longevity. Engaging with primary care throughout the cancer care trajectory may be important to support cardiovascular health.
Source: Journal of Cancer Survivorship - Category: Cancer & Oncology Source Type: research